<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34686697</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Swim training affects Akt signaling and ameliorates loss of skeletal muscle mass in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>20899</StartPage><MedlinePgn>20899</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20899</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-00319-1</ELocationID><Abstract><AbstractText>We tested the hypothesis that swim training reverses the impairment of Akt/FOXO3a signaling, ameliorating muscle atrophy in ALS mice. Transgenic male mice B6SJL-Tg (SOD1<sup>G93A</sup>) 1Gur/J were used as the ALS model (n&#x2009;=&#x2009;35), with wild-type B6SJL (WT) mice as controls (n&#x2009;=&#x2009;7). ALS mice were analyzed before ALS onset, at ALS onset, and at terminal ALS. Levels of insulin/Akt signaling pathway proteins were determined, and the body and tibialis anterior muscle mass and plasma creatine kinase. Significantly increased levels of FOXO3a in ALS groups (from about 13 to 21-fold) compared to WT mice were observed. MuRF1 levels in the ONSET untrained group (12.0&#x2009;&#xb1;&#x2009;1.7 AU) were significantly higher than in WT mice (1.12&#x2009;&#xb1;&#x2009;0.2 AU) and in the BEFORE ALS group (3.7&#x2009;&#xb1;&#x2009;0.9 AU). This was associated with body mass and skeletal muscle mass reduction. Swim training significantly ameliorated the reduction of skeletal muscle mass in both TERMINAL groups (p&#x2009;&lt;&#x2009;0.001) and partially reversed changes in the levels of Akt signaling pathway proteins. These findings shed light on the swimming-induced attenuation of skeletal muscle atrophy in ALS with possible practical implications for anti-cachexia approaches.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cieminski</LastName><ForeName>Karol</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Poznan University of Physical Education, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flis</LastName><ForeName>Damian Jozef</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Gdansk University of Physical Education and Sport, 80-336, Gdansk, Poland. damian.flis@gumed.edu.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Pathophysiology, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland. damian.flis@gumed.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzik</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Gdansk University of Physical Education and Sport, 80-336, Gdansk, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaczor</LastName><ForeName>Jan Jacek</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Gdansk University of Physical Education and Sport, 80-336, Gdansk, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czyrko</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Poznan University of Physical Education, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halon-Golabek</LastName><ForeName>Malgorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Health Sciences Medical, University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieckowski</LastName><ForeName>Mariusz Roman</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antosiewicz</LastName><ForeName>Jedrzej</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bioenergetics and Physiology of Exercise, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziolkowski</LastName><ForeName>Wieslaw</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Faculty of Health Sciences Medical, University of Gdansk, 80-219, Gdansk, Poland. wieslaw.ziolkowski@gumed.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071316">Forkhead Box Protein O3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071316" MajorTopicYN="N">Forkhead Box Protein O3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013550" MajorTopicYN="N">Swimming</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34686697</ArticleId><ArticleId IdType="pmc">PMC8536703</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-00319-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-00319-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390. doi: 10.1371/journal.pone.0005390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Halon-Golabek M, et al. hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway. J. Cachexia. Sarcopenia Muscle. 2018;9:557&#x2013;569. doi: 10.1002/jcsm.12283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12283</ArticleId><ArticleId IdType="pmc">PMC5989766</ArticleId><ArticleId IdType="pubmed">29380557</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicchitano BM, Dobrowolny G, Sica G, Musaro A. Molecular insights into muscle homeostasis, atrophy and wasting. Curr. Genomics. 2018;19:356&#x2013;369. doi: 10.2174/1389202919666180101153911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202919666180101153911</ArticleId><ArticleId IdType="pmc">PMC6030854</ArticleId><ArticleId IdType="pubmed">30065611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez AM, Bernardi H, Py G, Candau RB. Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014;307:R956&#x2013;969. doi: 10.1152/ajpregu.00187.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00187.2014</ArticleId><ArticleId IdType="pubmed">25121614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar BK, Frost LM, Christian L, Umapathi P, Gage FH. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann. Neurol. 2005;57:649&#x2013;655. doi: 10.1002/ana.20451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20451</ArticleId><ArticleId IdType="pubmed">15852403</ArticleId></ArticleIdList></Reference><Reference><Citation>Halon M, et al. Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation. Neuromusc. Disord. NMD. 2010;20:29&#x2013;33. doi: 10.1016/j.nmd.2009.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.08.014</ArticleId><ArticleId IdType="pubmed">19910193</ArticleId></ArticleIdList></Reference><Reference><Citation>Halon M, et al. Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation. Free Radic. Res. 2014;48:1363&#x2013;1370. doi: 10.3109/10715762.2014.955484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2014.955484</ArticleId><ArticleId IdType="pubmed">25175826</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S, et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 2009;587:3561&#x2013;3572. doi: 10.1113/jphysiol.2009.169748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.169748</ArticleId><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Desseille C, et al. Specific physical exercise improves energetic metabolism in the skeletal muscle of amyotrophic-lateral- sclerosis mice. Front. Mol. Neurosci. 2017;10:332. doi: 10.3389/fnmol.2017.00332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00332</ArticleId><ArticleId IdType="pmc">PMC5655117</ArticleId><ArticleId IdType="pubmed">29104532</ArticleId></ArticleIdList></Reference><Reference><Citation>Flis DJ, et al. Swim training modulates skeletal muscle energy metabolism, oxidative stress, and mitochondrial cholesterol content in amyotrophic lateral sclerosis mice. Oxid. Med. Cell. Longev. 2018;2018:5940748. doi: 10.1155/2018/5940748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5940748</ArticleId><ArticleId IdType="pmc">PMC5924974</ArticleId><ArticleId IdType="pubmed">29849903</ArticleId></ArticleIdList></Reference><Reference><Citation>Flis DJ, et al. Swim training modulates mouse skeletal muscle energy metabolism and ameliorates reduction in grip strength in a mouse model of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2019 doi: 10.3390/ijms20020233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020233</ArticleId><ArticleId IdType="pmc">PMC6359093</ArticleId><ArticleId IdType="pubmed">30634386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Qi J, Meng S, Wen B, Zhang J. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Eur. J. Appl. Physiol. 2013;113:2473&#x2013;2486. doi: 10.1007/s00421-013-2685-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-013-2685-9</ArticleId><ArticleId IdType="pubmed">23812090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. U.S.A. 2001;98:14440&#x2013;14445. doi: 10.1073/pnas.251541198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.251541198</ArticleId><ArticleId IdType="pmc">PMC64700</ArticleId><ArticleId IdType="pubmed">11717410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine SC, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001;3:1014&#x2013;1019. doi: 10.1038/ncb1101-1014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1101-1014</ArticleId><ArticleId IdType="pubmed">11715023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet. Muscle. 2011;1:4. doi: 10.1186/2044-5040-1-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-1-4</ArticleId><ArticleId IdType="pmc">PMC3143906</ArticleId><ArticleId IdType="pubmed">21798082</ArticleId></ArticleIdList></Reference><Reference><Citation>Musaro A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 2001;27:195&#x2013;200. doi: 10.1038/84839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/84839</ArticleId><ArticleId IdType="pubmed">11175789</ArticleId></ArticleIdList></Reference><Reference><Citation>Leger B, et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585. doi: 10.1096/fj.05-5249fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5249fje</ArticleId><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, et al. Superoxide anion radicals induce IGF-1 resistance through concomitant activation of PTP1B and PTEN. EMBO Mol. Med. 2015;7:59&#x2013;77. doi: 10.15252/emmm.201404082.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404082</ArticleId><ArticleId IdType="pmc">PMC4309668</ArticleId><ArticleId IdType="pubmed">25520316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai KM, et al. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell. Biol. 2004;24:9295&#x2013;9304. doi: 10.1128/MCB.24.21.9295-9304.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.21.9295-9304.2004</ArticleId><ArticleId IdType="pmc">PMC522257</ArticleId><ArticleId IdType="pubmed">15485899</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumiya Y, et al. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 2008;7:159&#x2013;172. doi: 10.1016/j.cmet.2007.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2007.11.003</ArticleId><ArticleId IdType="pmc">PMC2828690</ArticleId><ArticleId IdType="pubmed">18249175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori R, et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am. J. Physiol. Cell Physiol. 2009;296:C1248&#x2013;1257. doi: 10.1152/ajpcell.00104.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00104.2009</ArticleId><ArticleId IdType="pubmed">19357234</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochalova EP, Belova SP, Mirzoev TM, Shenkman BS, Nemirovskaya TL. Atrogin-1/MAFbx mRNA expression is regulated by histone deacetylase 1 in rat soleus muscle under hindlimb unloading. Sci. Rep. 2019;9:10263. doi: 10.1038/s41598-019-46753-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46753-0</ArticleId><ArticleId IdType="pmc">PMC6635498</ArticleId><ArticleId IdType="pubmed">31311969</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui Y. Pathological state or cause of sarcopenia. Clin. Calcium. 2017;27:45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28017945</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J, et al. Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation- or fasting-induced skeletal muscle atrophy. Front. Physiol. 2018;9:215. doi: 10.3389/fphys.2018.00215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00215</ArticleId><ArticleId IdType="pmc">PMC5861206</ArticleId><ArticleId IdType="pubmed">29593571</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 1999;344(Pt 2):427&#x2013;431. doi: 10.1042/bj3440427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3440427</ArticleId><ArticleId IdType="pmc">PMC1220660</ArticleId><ArticleId IdType="pubmed">10567225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates. Cell Death Dis. 2018;9:407. doi: 10.1038/s41419-018-0441-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0441-0</ArticleId><ArticleId IdType="pmc">PMC5851998</ArticleId><ArticleId IdType="pubmed">29540819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagey R, Pelech SL, Duronio V, Krieger C. Phosphatidylinositol 3-kinase: Increased activity and protein level in amyotrophic lateral sclerosis. J. Neurochem. 1998;71:716&#x2013;722. doi: 10.1046/j.1471-4159.1998.71020716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71020716.x</ArticleId><ArticleId IdType="pubmed">9681462</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N, Shaw PJ. Biomarkers in amyotrophic lateral sclerosis: A review of new developments. Curr. Opin. Neurol. 2020;33:662&#x2013;668. doi: 10.1097/WCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000854</ArticleId><ArticleId IdType="pubmed">32796280</ArticleId></ArticleIdList></Reference><Reference><Citation>Derave W, et al. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: Effects of creatine treatment. Neurobiol. Dis. 2003;13:264&#x2013;272. doi: 10.1016/s0969-9961(03)00041-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0969-9961(03)00041-x</ArticleId><ArticleId IdType="pubmed">12901841</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz MS, Sargeant M, Swash M. Longitudinal fibre splitting in neurogenic muscular disorders&#x2013;Its relation to the pathogenesis of "myopathic" change. Brain J. Neurol. 1976;99:617&#x2013;636. doi: 10.1093/brain/99.4.617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/99.4.617</ArticleId><ArticleId IdType="pubmed">192412</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington TM, Cohen MD, Bartleson JD, Ginsburg WW. Elevation of creatine kinase in amyotrophic lateral sclerosis. Potential confusion with polymyositis. Arthritis Rheum. 1983;26:201&#x2013;205. doi: 10.1002/art.1780260212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780260212</ArticleId><ArticleId IdType="pubmed">6824516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, et al. Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis. J. Neurol. 2019;266:2952&#x2013;2961. doi: 10.1007/s00415-019-09507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09507-6</ArticleId><ArticleId IdType="pubmed">31456060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccanti M, et al. creatine kinase and progression rate in amyotrophic lateral sclerosis. Cells. 2020 doi: 10.3390/cells9051174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051174</ArticleId><ArticleId IdType="pmc">PMC7291088</ArticleId><ArticleId IdType="pubmed">32397320</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamadeh MJ, Rodriguez MC, Kaczor JJ, Tarnopolsky MA. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve. 2005;31:214&#x2013;220. doi: 10.1002/mus.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20255</ArticleId><ArticleId IdType="pubmed">15625688</ArticleId></ArticleIdList></Reference><Reference><Citation>Weekes MP, et al. Quantitative temporal viromics: An approach to investigate host-pathogen interaction. Cell. 2014;157:1460&#x2013;1472. doi: 10.1016/j.cell.2014.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.04.028</ArticleId><ArticleId IdType="pmc">PMC4048463</ArticleId><ArticleId IdType="pubmed">24906157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>